Ізраїль - іврит - Ministry of Health

astrazeneca (israel) ltd - rosuvastatin as calcium - טבליות מצופות פילם - rosuvastatin as calcium 5 mg - rosuvastatin - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction ) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

Ізраїль - іврит - Ministry of Health

bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.

Ізраїль - іврит - Ministry of Health

bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.

Ізраїль - іврит - Ministry of Health

novartis israel ltd - diclofenac as potassium - טבליה - diclofenac as potassium 50 mg - diclofenac - diclofenac - management of pain and primary dysmenorrhea, when prompt pain relief is desired.

Ізраїль - іврит - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Ізраїль - іврит - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Ізраїль - іврит - Ministry of Health

teva israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 125 mg - deferasirox

Ізраїль - іврит - Ministry of Health

teva israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox

Ізраїль - іврит - Ministry of Health

teva israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 500 mg - deferasirox

Ізраїль - іврит - Ministry of Health

unipharm ltd, israel - amisulpride - טבליות מצופות פילם - amisulpride 100 mg - amisulpride